1. Home
  2. CAR vs DNLI Comparison

CAR vs DNLI Comparison

Compare CAR & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

N/A

Current Price

$126.11

Market Cap

3.9B

ML Signal

N/A

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$19.84

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAR
DNLI
Founded
1946
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.4B
IPO Year
1998
2017

Fundamental Metrics

Financial Performance
Metric
CAR
DNLI
Price
$126.11
$19.84
Analyst Decision
Hold
Strong Buy
Analyst Count
8
20
Target Price
★ $110.43
$36.19
AVG Volume (30 Days)
402.1K
★ 1.7M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 50.71
N/A
EPS
N/A
★ N/A
Revenue
★ $11,652,000,000.00
N/A
Revenue This Year
$0.09
N/A
Revenue Next Year
$1.39
$210.02
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$85.96
$15.34
52 Week High
$847.70
$27.30

Technical Indicators

Market Signals
Indicator
CAR
DNLI
Relative Strength Index (RSI) 65.64 51.25
Support Level $95.15 $19.12
Resistance Level $127.83 $20.84
Average True Range (ATR) 6.03 0.87
MACD 2.89 0.20
Stochastic Oscillator 90.18 42.17

Price Performance

Historical Comparison
CAR
DNLI

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: